SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-202149
Filing Date
2021-06-28
Accepted
2021-06-28 17:02:57
Documents
14
Period of Report
2021-06-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d159690d8k.htm   iXBRL 8-K 24841
2 EX-99.1 d159690dex991.htm EX-99.1 9242
6 GRAPHIC g159690g0629002748381.jpg GRAPHIC 3164
  Complete submission text file 0001193125-21-202149.txt   168542

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20210628.xsd EX-101.SCH 2916
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20210628_lab.xml EX-101.LAB 18908
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20210628_pre.xml EX-101.PRE 11879
7 EXTRACTED XBRL INSTANCE DOCUMENT d159690d8k_htm.xml XML 3532
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 211054362
SIC: 2834 Pharmaceutical Preparations